Page 348 - Traité de chimie thérapeutique 6 Médicaments antitumoraux

304 MEDICAMENTS INDUISANT OUSTABILISANT DES COUPURES DE L'ADN

BURDEN A., OSHEROFF N.. Mechanism of action of eukaryotic topoisomerase Il and
drugs targeted to the enzyme, Biochim. Biophys. Acta, 1998, 1400, 1-3, 139-154.
CAPRANICO G., BINASCHI M., DNA sequence selectivity of topoisomerases and topoi-
somerase poisons, Biochim. Biophys. Acta, 1998, 1400, 1-3, 185-194.
FAN Y. et al., Molecular modeling studies of the DNA-topoisomerase I ternary cleavable
complex with camptothecin, J. Med. Chem., 1998, 41, 2216-2226.
POMMIER Y. et al., Mechanism of action of eukaryotic DNA topoisomerase I and drugs
targeted to the enzyme, Biochim. Biophys. Acta, 1998, 1400, 1-3, 83-105.
REDINHO M.R. et al., Crystal structures of human topoisomerase I in covalent and non-
covalent complexes with DNA, Science, 1998, 279, 1504-1513.
STEWART L. et al., A model for the mechanism of human topoisomerase I, Science,
1998, 279, 1534-1540.
MONDRAGÔN A., DIGATE R., The structure of Escherichia coi DNA topoisomerase Ill,
Struct. Fold. Des., 1999, 7, 1373-1383.
CHAMPOUX J.J., DNA topisomerase : structure function, and mechanism, Annu. Rev.
Biochem., 2001, 70, 369-413.
CHANGELA A. et al., Crystal structure of complex of a type IA DNA topoisomerase with
a single-strauded DNA molecule, Nature, 2001, 411, 1077-1081.
Staker B.L. etal., The mecanism of topoisomerase I poisoning by a camptothecin analog,
Proc. Nat/. Acad. Sei. USA, 2002, 99, 15387-15392.